Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s ...

Compared to last year’s predictions, Eli Lilly’s Type 2 diabetes drug Mounjaro joined the top 10 list and secured the third spot with projected sales of nearly $20 billion. The three other GLP-1s on ...

Mounjaro (tirzepatide), a breakthrough drug for the treatment of Type 2 diabetes and obesity, has been released in India. The ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Here’s a list of some of the mild side effects Victoza ... All three drugs belong to different groups of diabetes drugs. They each come in different forms: Victoza is an injectable solution ...

This list does not contain all types of drugs ... If you take Ozempic with other diabetes medications that also lower blood sugar levels, your blood sugar levels might drop too low.

Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 billion between 2019 and 2023, a U.S. government watchdog's report showed this ...

The diabetes and weight loss drug market is heating up in 2025, with significant growth signs everywhere. According to a recent study from Research and Markets, industry growth is running at an ...